
Company valuation, historical trends, and peer comparisons.
According to Clene Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 67.11M. This represents a change of -14.02% compared to the average of 78.06M of the last 4 quarters.
The mean historical Enterprise Value of Clene Inc. over the last ten years is 264.13M. The current 67.11M Enterprise Value has changed -74.59% with respect to the historical average. Over the past ten years (40 quarters), CLNN's Enterprise Value was at its highest in in the June 2020 quarter at 749.09M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
264.13M
Median
78.70M
Minimum
0
Maximum
721.72M
Discovering the peaks and valleys of Clene Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 721.72M
Minimum Annual Increase = -65.20%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 74.36M | 63.01% |
| 2024 | 45.61M | 32.39% |
| 2023 | 34.45M | -56.22% |
| 2022 | 78.70M | -65.20% |
| 2021 | 226.14M | -60.73% |
| 2020 | 575.89M | -20.21% |
| 2019 | 721.72M | 16.36% |
| 2018 | 620.26M | Infinity% |
The current Enterprise Value of Clene Inc. (CLNN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
51.47M
5-year avg
91.85M
10-year avg
264.13M
Clene Inc.’s Enterprise Value is less than MacroGenics, Inc. (78.21M), less than Ovid Therapeutics Inc. (479.87M), greater than Coya Therapeutics, Inc. (36.11M), less than Oramed Pharmaceuticals Inc. (153.96M), less than Whitehawk Therapeutics Inc (94.34M), greater than Context Therapeutics Inc. (-24176597.00), less than Zentalis Pharmaceuticals, Inc. (148.16M), less than Shattuck Labs, Inc. (474.25M), greater than Pliant Therapeutics, Inc. (56.56M), greater than Connect Biopharma Holdings Limited (22.06M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 78.21M | $157.02M | |
| 479.87M | $478.48M | |
| 36.11M | $79.29M | |
| 153.96M | $168.47M | |
| 94.34M | $179.58M | |
| -24176597.00 | $18.57M | |
| 148.16M | $135.25M | |
| 474.25M | $534.87M | |
| 56.56M | $52.70M | |
| 22.06M | $48.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clene Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Clene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Clene Inc.'s Enterprise Value?
What is the highest Enterprise Value for Clene Inc. (CLNN)?
What is the 3-year average Enterprise Value for Clene Inc. (CLNN)?
What is the 5-year average Enterprise Value for Clene Inc. (CLNN)?
How does the current Enterprise Value for Clene Inc. (CLNN) compare to its historical average?